Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
N
NovaBay Pharmaceuticals Inc
AMEX:SDEV
NovaBay Pharmaceuticals Inc
AMEX:SDEV
Price:
1.02
USD
3.03%
Market Closed
Market Cap:
$51.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
B
|
Becton Dickinson and Co
F:BOX
|
US |
|
Imperial Oil Ltd
TSX:IMO
|
CA |
|
T
|
TXT e solutions SpA
F:TXE
|
IT |
|
Pensana PLC
LSE:PRE
|
UK |
|
P
|
Pioneer Motor PCL
SET:PIMO
|
TH |
|
Fom Technologies A/S
CSE:FOM
|
DK |
|
C
|
Chow Steel Industries PCL
SET:CHOW
|
TH |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SDEV's stock price target?
Not Available
SDEV does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for NovaBay Pharmaceuticals Inc?
Projected CAGR
29%
29%
Over the last 12 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is 29%.
What is the Gross Profit forecast for NovaBay Pharmaceuticals Inc?
Projected CAGR
-21%
-21%
The compound annual growth rate for Gross Profit over the next -1 years is -21%.